Devices and techniques for endoscopic treatment of residual and fibrotic colorectal polyps (with videos)

Arvind J. Trindade, Nikhil A. Kumta, Manoop S. Bhutani, Vinay Chandrasekhara, Pichamol Jirapinyo, Kumar Krishnan, Joshua Melson, Rahul Pannala, Mansour A. Parsi, Allison R. Schulman, Guru Trikudanathan, Rabindra R. Watson, John T. Maple, David R. Lichtenstein

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Background and Aims: Residual neoplasia after macroscopically complete EMR of large colon polyps has been reported in 10% to 32% of resections. Often, residual polyps at the site of prior polypectomy are fibrotic and nonlifting, making additional resection challenging. Methods: This document reviews devices and methods for the endoscopic treatment of fibrotic and/or residual polyps. In addition, techniques reported to reduce the incidence of residual neoplasia after endoscopic resection are discussed. Results: Descriptions of technologies and available outcomes data are summarized for argon plasma coagulation ablation, snare-tip coagulation, avulsion techniques, grasp-and-snare technique, EndoRotor endoscopic resection system, endoscopic full-thickness resection device, and salvage endoscopic submucosal dissection. Conclusions: Several technologies and techniques discussed in this document may aid in the prevention and/or resection of fibrotic and nonlifting polyps.

Original languageEnglish (US)
Pages (from-to)474-482
Number of pages9
JournalGastrointestinal endoscopy
Volume92
Issue number3
DOIs
StatePublished - Sep 2020

Bibliographical note

Funding Information:
DISCLOSURE: The following authors disclosed financial relationships: N. Kumta: Consultant for Boston Scientific, Olympus Corporation of the Americas, Gyrus ACMI, Inc, and Apollo Endosurgery US Inc. A. Trindade: Consultant for Olympus Corporation of the Americas and PENTAX of America, Inc; food and beverage support from Boston Scientific; research grant from NinePoint Medical, Inc. M. Bhutani: Research grant from Silenseed Inc, Galera Inc, Oncosil Inc, and Augmenix Inc; food, beverage, or travel support from Boston Scientific, Augmentix, and Conmed Corporation. V. Chandrasekhara: Advisory board for Interpace Diagnostics; shareholder in Nevakar, Inc. P. Jirapinyo: Consultant for GI Dynamics and Endogastric Solutions; research support from GI Dynamics, Apollo Endosurgery, and Fractyl. K. Krishnan: Consultant for Olympus Medical; D. Lichtenstein: Consultant for Allergan Inc, Augmenix, Gyrus ACMI, Inc, and Olympus Corporation of the Americas; speaker for Aries Pharmaceutical, Gyrus ACMI, Inc, and Olympus Corporation of the Americas; tuition payment from Erbe USA Inc. J. Melson: Investigator-initiated grant from Boston Scientific; stock options with Virgo Imaging. R. Pannala: Consultant for HCL Technologies; travel compensation from Boston Scientific Corporation; stockholder in AbbVie. A. Schulman: Consultant for Boston Scientific, Apollo Endosurgery, and MicroTech; research funding from GI Dynamics. G. Trikudanathan: Speaker, honorarium, and travel from Boston Scientific; advisory board for Abbvie. R. Watson: Consultant for Apollo Endosurgery, Boston Scientific, Medtronic, and Neptune Medical Inc; speaker for Apollo Endosurgery and Boston Scientific.

Funding Information:
DISCLOSURE: The following authors disclosed financial relationships: N. Kumta: Consultant for Boston Scientific, Olympus Corporation of the Americas, Gyrus ACMI, Inc, and Apollo Endosurgery US Inc. A. Trindade: Consultant for Olympus Corporation of the Americas and PENTAX of America, Inc; food and beverage support from Boston Scientific; research grant from NinePoint Medical, Inc. M. Bhutani: Research grant from Silenseed Inc, Galera Inc, Oncosil Inc, and Augmenix Inc; food, beverage, or travel support from Boston Scientific, Augmentix, and Conmed Corporation. V. Chandrasekhara: Advisory board for Interpace Diagnostics; shareholder in Nevakar, Inc. P. Jirapinyo: Consultant for GI Dynamics and Endogastric Solutions; research support from GI Dynamics, Apollo Endosurgery, and Fractyl. K. Krishnan: Consultant for Olympus Medical; D. Lichtenstein: Consultant for Allergan Inc, Augmenix, Gyrus ACMI, Inc, and Olympus Corporation of the Americas; speaker for Aries Pharmaceutical, Gyrus ACMI, Inc, and Olympus Corporation of the Americas; tuition payment from Erbe USA Inc. J. Melson: Investigator-initiated grant from Boston Scientific; stock options with Virgo Imaging. R. Pannala: Consultant for HCL Technologies; travel compensation from Boston Scientific Corporation; stockholder in AbbVie. A. Schulman: Consultant for Boston Scientific, Apollo Endosurgery, and MicroTech; research funding from GI Dynamics. G. Trikudanathan: Speaker, honorarium, and travel from Boston Scientific; advisory board for Abbvie. R. Watson: Consultant for Apollo Endosurgery, Boston Scientific, Medtronic, and Neptune Medical Inc; speaker for Apollo Endosurgery and Boston Scientific.

Publisher Copyright:
© 2020 American Society for Gastrointestinal Endoscopy

Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.

PubMed: MeSH publication types

  • Journal Article

Fingerprint Dive into the research topics of 'Devices and techniques for endoscopic treatment of residual and fibrotic colorectal polyps (with videos)'. Together they form a unique fingerprint.

Cite this